Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Lower Motor Neuron Involvement in Als Assessed by Motor Unit Number Index (Munix): Long-Term Changes and Reproducibility Publisher Pubmed



Fathi D1, 2 ; Mohammadi B2, 3 ; Dengler R4 ; Boselt S4 ; Petri S4 ; Kollewe K4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. International Neuroscience Institute, Hannover, Germany
  3. 3. Department of Neurology, University of Lubeck, Lubeck, Germany
  4. 4. Department of Neurology, Hannover Medical School, Hannover, Germany

Source: Clinical Neurophysiology Published:2016


Abstract

Objective: Motor unit number estimation (MUNE) techniques such as motor unit number index (MUNIX) have been used to quantify lower motor neuron loss and disease progression in amyotrophic lateral sclerosis (ALS). We investigated the consistency of reproducibility of MUNIX in 30 ALS-patients during the course of the disorder. Methods: MUNIX was recorded in abductor pollicis brevis and tibialis anterior muscles bilaterally in ALS-patients by two measurements at the first and at one follow-up visit and once in healthy controls. Intra-rater reproducibility was evaluated by three statistical methods: interclass correlation coefficient (ICC), correlation coefficient analysis (CCA), and coefficient of variation (CV). Results: We found significant correlation between the first and second measurement of MUNIX in all tested muscles and at the follow-up visit (r ≥ 0.891, p < 0.01) and good statistically significant reproducibility of MUNIX in all four measured muscles at the follow-up visit (ICC ≥ 0.946, p < 0.01). The CV of MUNIX at the follow-up visit ranged from 13.90% to 32.95%. Conclusions: This study shows good consistency of reproducibility of MUNIX in the course of ALS. Significance: This study suggests that MUNIX can be used to track the progression of the disorder both in clinical routine and in treatment trials. © 2016 International Federation of Clinical Neurophysiology.